Who can take part?
What is involved for you?
There are two distinct sets of pathways during RSV Season 1 (April 2023 to September 2023, approximately) During RSV Season 1:
- Participants in either study arm will receive the intervention on Day 1 and Day 28
- On day 60, participants on both arms will be unblinded (told what study arm they are in), with:
- Control participants receiving additional dosages on day 60, 90, and 120 alongside safety follow-ups for a year
- Intervention arm participants will receive safety follow-ups for a year
Some participants in both arms will be legible to join the RSV Season 2 (April 2024 to September 2024, approximately) phase, which involves:
- All participants receiving the new study intervention regardless of what arm they were in previously
- Safety follow-ups through until day 180 post dosage
Participants in both arms will also receive full physical examinations, blood withdrawals, and buccal swabs (DNA) for future biomedical research (optional).
Trial dates
This trial will be open for enrolment in April 2023.